Suzanne Vernon: Difference between revisions
Notjusttired (talk | contribs) m (Text replacement - "ref>{{Cite journal|last=Harvey|first=Jeanna M.|last2=Broderick|first2=Gordon|last3=Bowie|first3=Alanna|last4=Barnes|first4=Zachary M.|last5=Katz|first5=Ben Z.|last6=O’Gorman|first6=Maurice R. G.|last7=Vernon|first7=Suzanne D.|last...) |
Notjusttired (talk | contribs) m (fix ref) |
||
(2 intermediate revisions by the same user not shown) | |||
Line 2: | Line 2: | ||
'''Suzanne D. Vernon''', PhD, is the Research Liaison at [[Bateman Horne Center]] of Excellence which specializes in treatment and research for [[ME/CFS]] and [[Fibromyalgia]]<ref name=":0">{{Cite web|url=https://batemanhornecenter.org/suzanne-d-vernon-phd/|title=Suzanne D. Vernon, PhD|website=Bateman Horne Center|language=en-US|access-date=2019-02-02}}</ref> and the Chief Scientific Revolutionary of The BioCollective, a collaborative that provides storage and sales of [[microbiome]] samples for research and development.<ref>http://www.thebiocollective.com/about-us/</ref> | '''Suzanne D. Vernon''', PhD, is the Research Liaison at [[Bateman Horne Center]] of Excellence which specializes in treatment and research for [[ME/CFS]] and [[Fibromyalgia]]<ref name=":0">{{Cite web|url=https://batemanhornecenter.org/suzanne-d-vernon-phd/|title=Suzanne D. Vernon, PhD|website=Bateman Horne Center|language=en-US|access-date=2019-02-02}}</ref> and the Chief Scientific Revolutionary of The BioCollective, a collaborative that provides storage and sales of [[microbiome]] samples for research and development.<ref>http://www.thebiocollective.com/about-us/</ref> | ||
From November 2007 | From November 2007 to May 2015, Dr. Vernon was the Scientific Director of [[Solve ME/CFS Initiative]], formerly known as CFIDS Association of America.<ref>{{Cite web|url=https://solvecfs.org/suzanne-d-vernon-steps-down-from-scientific-director-post/|title=Suzanne D. Vernon Steps Down from Scientific Director Post|date=2015-04-08|website=Solve ME/CFS Initiative|language=en-US|access-date=2019-02-02}}</ref> While there she recognized that access to well-characterized clinical populations was a barrier to engaging more scientists in ME/CFS research. Thus, she started the Research Institute Without Walls (RIWW), "the first nonprofit patient-centered research initiative focused on identifying diagnostic biomarkers and disease-modifying treatment for ME/CFS.<ref name=":0" /> The core of RIWW is the [[SolveCFS BioBank & Patient Registry]].<ref>{{Cite web|url=https://solvecfs.org/about-us/advancing-science-a-case-for-hope-a-look-ahead/|title=Advancing Science: A Case for Hope, A Look Ahead|website=Solve ME/CFS Initiative|language=en-US|access-date=2019-06-25}}</ref> | ||
From May 1990 | From May 1990 to October 2007, Dr. Vernon worked for the US [[Centers for Disease Control]], first on the team investigating the human papillomavirus as an opportunistic infection in HIV-infected woman, and then in 1997, she became the CFS research group team leader, under [[William Reeves]], MD, the Director of the CDC Chronic Fatigue Research Program.<ref>https://www.linkedin.com/in/suzanne-d-vernon-phd-2743a617</ref><ref>{{Cite news|url=https://www.nytimes.com/2012/08/09/health/dr-william-c-reeves-who-sought-cause-of-fatigue-syndrome-dies-at-69.html|title=Dr. William C. Reeves, Who Sought Cause of Fatigue Syndrome, Dies at 69|last=Grady|first=Denise|date=2012-08-08|work=The New York Times|access-date=2019-02-02|language=en-US|issn=0362-4331}}</ref> | ||
In 2005, Dr Vernon was one of the authors of the [[Centers for Disease Control and Prevention|CDC]] case definition of [[Chronic fatigue syndrome|CFS]], commonly called the [[Reeves criteria]].<ref name=":1">{{Cite journal|last=Reeves|first=William C|author-link=William Reeves|last2=Wagner|first2=Dieter|author-link2=|last3=Nisenbaum|first3=Rosane|author-link3=|last4=Jones|first4=James F|author-link4=|last5=Gurbaxani|first5=Brian|author-link5=|last6=Solomon|first6=Laura|author-link6=|last7=Papanicolaou|first7=Dimitris A|last8=Unger|first8=Elizabeth R|author-link8=Elizabeth Unger|last9=Vernon|first9=Suzanne D|author-link9=Suzanne Vernon|date=Dec 2005|title=Chronic Fatigue Syndrome – A clinically empirical approach to its definition and study|url=http://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-3-19|journal=BMC Medicine|language=en|volume=3|issue= | In 2005, Dr Vernon was one of the authors of the [[Centers for Disease Control and Prevention|CDC]] case definition of [[Chronic fatigue syndrome|CFS]], commonly called the [[Reeves criteria]].<ref name=":1">{{Cite journal|last=Reeves|first=William C|author-link=William Reeves|last2=Wagner|first2=Dieter|author-link2=|last3=Nisenbaum|first3=Rosane|author-link3=|last4=Jones|first4=James F|author-link4=|last5=Gurbaxani|first5=Brian|author-link5=|last6=Solomon|first6=Laura|author-link6=|last7=Papanicolaou|first7=Dimitris A|last8=Unger|first8=Elizabeth R|author-link8=Elizabeth Unger|last9=Vernon|first9=Suzanne D|author-link9=Suzanne Vernon|date=Dec 2005|title=Chronic Fatigue Syndrome – A clinically empirical approach to its definition and study|url=http://bmcmedicine.biomedcentral.com/articles/10.1186/1741-7015-3-19|journal=BMC Medicine|language=en|volume=3|issue=|pages=19|doi=10.1186/1741-7015-3-19|issn=1741-7015|quote=|via=}}</ref> | ||
==Talks and interviews== | ==Talks and interviews== | ||
Line 16: | Line 16: | ||
==Studies and Articles== | ==Studies and Articles== | ||
*2003, Identification of ambiguities in the [[Fukuda criteria|1994 chronic fatigue syndrome research case definition]] and recommendations for resolution<ref name="Reeves,2003">{{ | *2003, Identification of ambiguities in the [[Fukuda criteria|1994 chronic fatigue syndrome research case definition]] and recommendations for resolution<ref name="Reeves,2003">{{Cite journal |last1=Reeves|first1=W.C.|authorlink1=William Reeves|last2=Lloyd|first2=A.|authorlink2=Andrew Lloyd|last3=Vernon|first3=S.D.|authorlink3=Suzanne Vernon|last4=Klimas|first4=N.|authorlink4=Nancy Klimas|last5=Jason|first5=L.A.|authorlink5=Leonard Jason|last6=Bleijenberg|first6=G.|authorlink6=Gijs Bleijenberg|last7=Evengard|first7=B.|authorlink7=Birgitta Evengård|last8=White|first8=P.D.|authorlink8=Peter White|last9=Nisenbaum|first9=R.|authorlink9=Rosane Nisenbaum|last10=Unger|first10=E.|authorlink10=Elizabeth Unger|title=Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution|journal=BMC Health Services Research|volume=3|issue=|pages=25|url=https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-3-25|date=2003|doi=10.1186/1472-6963-3-25}}</ref> - [https://bmchealthservres.biomedcentral.com/articles/10.1186/1472-6963-3-25 (Full Text)] | ||
*2003, Integration of [[gene expression]], clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome<ref>{{Cite journal|last=Whistler|first=Toni|author-link=Toni Whistler|last2=Unger|first2=Elizabeth R.|author-link2=Elizabeth Unger|last3=Nisenbaum|first3=Rosane|author-link3=Rosane Nisenbaum|last4=Vernon|first4=Suzanne D.|author-link4=Suzanne Vernon|author-link5=|date=Dec 1, 2003|title=Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome|url=https://doi.org/10.1186/1479-5876-1-10|journal=Journal of Translational Medicine|volume=1|issue= | *2003, Integration of [[gene expression]], clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome<ref>{{Cite journal|last=Whistler|first=Toni|author-link=Toni Whistler|last2=Unger|first2=Elizabeth R.|author-link2=Elizabeth Unger|last3=Nisenbaum|first3=Rosane|author-link3=Rosane Nisenbaum|last4=Vernon|first4=Suzanne D.|author-link4=Suzanne Vernon|author-link5=|date=Dec 1, 2003|title=Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome|url=https://doi.org/10.1186/1479-5876-1-10|journal=Journal of Translational Medicine|volume=1|issue=|pages=10|doi=10.1186/1479-5876-1-10|issn=1479-5876|pmc=305360|pmid=14641939|quote=|via=}}</ref> - [https://doi.org/10.1186/1479-5876-1-10 (Full Text)] | ||
*2004, Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome<ref>{{Cite journal|last=Rajeevan|first=Mangalathu S.|author-link=Mangalathu Rajeevan|last2=Jones|first2=James F.|author-link2=|last3=Vernon|first3=Suzanne D.|author-link3=Suzanne Vernon|last4=Unger|first4=Elizabeth R.|author-link4=Elizabeth Unger|last5=Steinau|first5=Martin|author-link5=|date=2004-11-01|title=Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome|url=https://link.springer.com/article/10.1007/s00109-004-0586-4|journal=Journal of Molecular Medicine|language=en|volume=82|issue=11|pages=750–755|doi=10.1007/s00109-004-0586-4|issn=1432-1440|quote=|via=}}</ref> [[pubmed:15490094|(Abstract)]] | *2004, Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome<ref>{{Cite journal|last=Rajeevan|first=Mangalathu S.|author-link=Mangalathu Rajeevan|last2=Jones|first2=James F.|author-link2=|last3=Vernon|first3=Suzanne D.|author-link3=Suzanne Vernon|last4=Unger|first4=Elizabeth R.|author-link4=Elizabeth Unger|last5=Steinau|first5=Martin|author-link5=|date=2004-11-01|title=Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome|url=https://link.springer.com/article/10.1007/s00109-004-0586-4|journal=Journal of Molecular Medicine|language=en|volume=82|issue=11|pages=750–755|doi=10.1007/s00109-004-0586-4|issn=1432-1440|quote=|via=}}</ref> - [[pubmed:15490094|(Abstract)]] | ||
*2005, [[Chronic Fatigue Syndrome]] – A clinically empirical approach to its definition and study<ref name=":1" /> | *2005, [[Chronic Fatigue Syndrome]] – A clinically empirical approach to its definition and study<ref name=":1" /> | ||
*2006, Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study<ref>{{Cite journal|last=Hickie|first=Ian|author-link=Ian Hickie|last2=Davenport|first2=Tracey|author-link2=Tracey Davenport|last3=Wakefield|first3=Denis|author-link3=Denis Wakefield|last4=Vollmer-Conna|first4=Ute|author-link4=Uté Vollmer-Conna|last5=Cameron|first5=Barbara|author-link5=Barbara Cameron|last6=Vernon|first6=Suzanne D|author-link6=Suzanne Vernon|last7=Reeves|first7=William C|author-link7=William Reeves|last8=Lloyd|first8=Andrew|author-link8=Andrew Lloyd|date=2006-09-16|title=Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study|url=http://www.bmj.com/lookup/doi/10.1136/bmj.38933.585764.AE|journal=BMJ|volume=333|issue=7568|pages=575–|doi=10.1136/bmj.38933.585764.ae|pmc=1569956|pmid=16950834|quote=|via=}}</ref>[https://www.researchgate.net/publication/6838807_Post-infective_and_chronic_fatigue_syndromes_precipitated_by_viral_and_non-viral_pathogens_Prospective_cohort_study (Abstract)] | *2006, Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study<ref>{{Cite journal|last=Hickie|first=Ian|author-link=Ian Hickie|last2=Davenport|first2=Tracey|author-link2=Tracey Davenport|last3=Wakefield|first3=Denis|author-link3=Denis Wakefield|last4=Vollmer-Conna|first4=Ute|author-link4=Uté Vollmer-Conna|last5=Cameron|first5=Barbara|author-link5=Barbara Cameron|last6=Vernon|first6=Suzanne D|author-link6=Suzanne Vernon|last7=Reeves|first7=William C|author-link7=William Reeves|last8=Lloyd|first8=Andrew|author-link8=Andrew Lloyd|date=2006-09-16|title=Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study|url=http://www.bmj.com/lookup/doi/10.1136/bmj.38933.585764.AE|journal=BMJ|volume=333|issue=7568|pages=575–|doi=10.1136/bmj.38933.585764.ae|pmc=1569956|pmid=16950834|quote=|via=}}</ref> - [https://www.researchgate.net/publication/6838807_Post-infective_and_chronic_fatigue_syndromes_precipitated_by_viral_and_non-viral_pathogens_Prospective_cohort_study (Abstract)] | ||
*2006, Preliminary evidence of [[mitochondrion|mitochondrial]] dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus<ref name="Vernon, 2006" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1373655/ (Full Text)] | *2006, Preliminary evidence of [[mitochondrion|mitochondrial]] dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus<ref name="Vernon, 2006" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1373655/ (Full Text)] | ||
*2008, Neuroendocrine and immune network remodeling in chronic fatigue syndrome: an exploratory analysis<ref name="Fuite, 2010" /> [https://www.sciencedirect.com/science/article/pii/S0888754308001948 | *2008, Neuroendocrine and immune network remodeling in chronic fatigue syndrome: an exploratory analysis<ref name="Fuite, 2010" /> - [https://www.sciencedirect.com/science/article/pii/S0888754308001948 (Full Text)] | ||
*2008, Evidence of inflammatory immune signaling in [[chronic fatigue syndrome]]: A pilot study of gene expression in peripheral blood.<ref name="Aspler, 2008" /> [http://psycnet.apa.org/record/2008-15631-001 (Abstract)] | *2008, Evidence of inflammatory immune signaling in [[chronic fatigue syndrome]]: A pilot study of gene expression in peripheral blood.<ref name="Aspler, 2008" /> - [http://psycnet.apa.org/record/2008-15631-001 (Abstract)] | ||
*2009, Transcriptional control of complement activation in an [[exercise]] model of [[chronic fatigue syndrome]]<ref>{{Cite journal|last=Sorensen|first=Bristol|author-link=|last2=Jones|first2=James F|author-link2=|last3=Vernon|first3=Suzanne D|author-link3=Suzanne Vernon|last4=Rajeevan|first4=Mangalathu S|author-link4=Mangalathu Rajeevan|author-link5=|date=Jan 2009|title=Transcriptional Control of Complement Activation in an Exercise Model of Chronic Fatigue Syndrome|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583111/|journal=Molecular Medicine|volume=15|issue=1-2|pages=34–42|doi=10.2119/molmed.2008.00098|pmc=2583111|pmid=19015737|quote=|via=}}</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583111/pdf/mol-15-34.pdf (Full text)] | *2009, Transcriptional control of complement activation in an [[exercise]] model of [[chronic fatigue syndrome]]<ref>{{Cite journal|last=Sorensen|first=Bristol|author-link=|last2=Jones|first2=James F|author-link2=|last3=Vernon|first3=Suzanne D|author-link3=Suzanne Vernon|last4=Rajeevan|first4=Mangalathu S|author-link4=Mangalathu Rajeevan|author-link5=|date=Jan 2009|title=Transcriptional Control of Complement Activation in an Exercise Model of Chronic Fatigue Syndrome|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583111/|journal=Molecular Medicine|volume=15|issue=1-2|pages=34–42|doi=10.2119/molmed.2008.00098|pmc=2583111|pmid=19015737|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2583111/pdf/mol-15-34.pdf (Full text)] | ||
*2012, [[Cytokine]] expression profiles of immune imbalance in post-[[mononucleosis]] chronic fatigue<ref name="Broderick, 2012" /> | *2012, [[Cytokine]] expression profiles of immune imbalance in post-[[mononucleosis]] chronic fatigue<ref name="Broderick, 2012" /> - | ||
*2014, No association found between the detection of either [[xenotropic murine leukemia virus-related virus]] or polytropic murine leukemia virus and [[chronic fatigue syndrome]] in a blinded, multi-site, prospective study by the establishment and use of the [[SolveCFS BioBank & Patient Registry|SolveCFS BioBank]]<ref>{{Cite journal|last=Irlbeck|first=David M.|last2=Vernon|first2=Suzanne D.|author-link2=Suzanne Vernon|last3=McCleary|first3=K. Kimberly|author-link3=Kim McCleary|last4=Bateman|first4=Lucinda|author-link4=Lucinda Bateman|last5=Klimas|first5=Nancy G.|author-link5=Nancy Klimas|last6=Lapp|first6=Charles W.|author-link6=Charles Lapp|last7=Peterson|first7=Daniel L.|author-link7=Daniel Peterson|last8=Brown|first8=James R.|last9=Remlinger|first9=Katja S.|date=2014|title=No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236736/|journal=BMC Research Notes|volume=7|pages=461|doi=10.1186/1756-0500-7-461|via= | *2014, No association found between the detection of either [[xenotropic murine leukemia virus-related virus]] or polytropic murine leukemia virus and [[chronic fatigue syndrome]] in a blinded, multi-site, prospective study by the establishment and use of the [[SolveCFS BioBank & Patient Registry|SolveCFS BioBank]]<ref>{{Cite journal|last=Irlbeck|first=David M.|last2=Vernon|first2=Suzanne D.|author-link2=Suzanne Vernon|last3=McCleary|first3=K. Kimberly|author-link3=Kim McCleary|last4=Bateman|first4=Lucinda|author-link4=Lucinda Bateman|last5=Klimas|first5=Nancy G.|author-link5=Nancy Klimas|last6=Lapp|first6=Charles W.|author-link6=Charles Lapp|last7=Peterson|first7=Daniel L.|author-link7=Daniel Peterson|last8=Brown|first8=James R.|last9=Remlinger|first9=Katja S.|last10=Wilfret|last11=Gerondelis|first11=Peter|first10=David A.|date=2014|title=No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236736/|journal=BMC Research Notes|volume=7|pages=461|doi=10.1186/1756-0500-7-461|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4236736/ (Full Text)] | ||
*2014, Examining case definition criteria for [[chronic fatigue syndrome]] and [[myalgic encephalomyelitis]]<ref name="Jason, LA, 2014" /> | *2014, Examining case definition criteria for [[chronic fatigue syndrome]] and [[myalgic encephalomyelitis]]<ref name="Jason, LA, 2014" /> - | ||
*2015, [[Chronic fatigue syndrome]] versus [[Systemic Exertion Intolerance Disease|systemic exertion intolerance disease]]]<ref name="Jason, Sunn, 2015" /> [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1051291 (Abstract)] | *2015, [[Chronic fatigue syndrome]] versus [[Systemic Exertion Intolerance Disease|systemic exertion intolerance disease]]]<ref name="Jason, Sunn, 2015" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1051291 (Abstract)] - | ||
*2015, Comparing and contrasting consensus versus empirical domains<ref name="Jason, Kot, 2015" /> [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1017344 (Abstract)] | *2015, Comparing and contrasting consensus versus empirical domains<ref name="Jason, Kot, 2015" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1017344 (Abstract)] - | ||
*2015, Changes in Gut and Plasma [[Microbiome]] following [[Exercise]] Challenge in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)]]<ref name="Shukla, 2015" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684203/ (Full Text)] | *2015, Changes in Gut and Plasma [[Microbiome]] following [[Exercise]] Challenge in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)]]<ref name="Shukla, 2015" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684203/ (Full Text)] | ||
*2016, The utility of patient-reported outcome measures among patients with [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Murdock, 2016">{{Cite journal| last1 = Murdock | first1 = KW | authorlink1 = | *2016, The utility of patient-reported outcome measures among patients with [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Murdock, 2016">{{Cite journal| last1 = Murdock | first1 = KW | authorlink1 = | ||
| last2 = Wang | first2 = XS | authorlink2 = | | last2 = Wang | first2 = XS | authorlink2 = | ||
Line 36: | Line 36: | ||
| last4 = Cleeland | first4 = CS | authorlink4 = | | last4 = Cleeland | first4 = CS | authorlink4 = | ||
| last5 = Fagundes | first5 = CP | authorlink5 = | | last5 = Fagundes | first5 = CP | authorlink5 = | ||
| last6 = Vernon | first6 = Suzanne D. | authorlink6 = Suzanne Vernon| title = The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.| journal = Quality of Life Research | volume = 26 | issue = | pages = 913–921 | date = 2016| pmid = 27600520 | pmc = PMC5336422| doi = 10.1007/s11136-016-1406-3 | url = https://link.springer.com/article/10.1007/s11136-016-1406-3}}</ref> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336422/ (Full Text)] | | last6 = Vernon | first6 = Suzanne D. | authorlink6 = Suzanne Vernon| title = The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome.| journal = Quality of Life Research | volume = 26 | issue = | pages = 913–921 | date = 2016| pmid = 27600520 | pmc = PMC5336422| doi = 10.1007/s11136-016-1406-3 | url = https://link.springer.com/article/10.1007/s11136-016-1406-3}}</ref> -[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5336422/ (Full Text)] | ||
*2016, Tracking post-infectious fatigue in clinic using routine Lab tests<ref name="Harvey2016">{{Cite journal|last=Harvey|first=Jeanna M.|author-link=Jeanna Harvey|last2=Broderick|first2=Gordon|author-link2=Gordon Broderick|last3=Bowie|first3=Alanna|author-link3=Alanna Bowie|last4=Barnes|first4=Zachary M.|author-link4=Zachary Barnes|last5=Katz|first5=Ben Z.|author-link5=Ben Katz|last6=O'Gorman|first6=Maurice R. G.|author-link6=Maurice O'Gorman|last7=Vernon|first7=Suzanne D.|author-link7=Suzanne Vernon|last8=Fletcher|first8=Mary Ann|author-link8=Mary Ann Fletcher|last9=Klimas|first9=Nancy G.|author-link9=Nancy Klimas|date=2016-04-26|title=Tracking post-infectious fatigue in clinic using routine Lab tests|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847210/|journal=BMC Pediatrics|doi=10.1186/s12887-016-0596-8|issn=1471-2431|pmc=4847210|pmid=27118537|volume=15|issue=|pages=54|quote= | *2016, Tracking post-infectious fatigue in clinic using routine Lab tests<ref name="Harvey2016">{{Cite journal|last=Harvey|first=Jeanna M.|author-link=Jeanna Harvey|last2=Broderick|first2=Gordon|author-link2=Gordon Broderick|last3=Bowie|first3=Alanna|author-link3=Alanna Bowie|last4=Barnes|first4=Zachary M.|author-link4=Zachary Barnes|last5=Katz|first5=Ben Z.|author-link5=Ben Katz|last6=O'Gorman|first6=Maurice R. G.|author-link6=Maurice O'Gorman|last7=Vernon|first7=Suzanne D.|author-link7=Suzanne Vernon|last8=Fletcher|first8=Mary Ann|author-link8=Mary Ann Fletcher|last9=Klimas|first9=Nancy G.|author-link9=Nancy Klimas|date=2016-04-26|title=Tracking post-infectious fatigue in clinic using routine Lab tests|url=https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4847210/|journal=BMC Pediatrics|doi=10.1186/s12887-016-0596-8|issn=1471-2431|pmc=4847210|pmid=27118537|volume=15|issue=|pages=54|quote=}}</ref> - [https://bmcpediatr.biomedcentral.com/articles/10.1186/s12887-016-0596-8 (Full Text)] | ||
*2016, Current therapeutic strategies for [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]: results of an online survey<ref name="Deftereos, 2016" /> [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1126025 (Abstract)] | *2016, Current therapeutic strategies for [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]: results of an online survey<ref name="Deftereos, 2016" /> - [http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1126025 (Abstract)] | ||
*2016, Article - [https://batemanhornecenter.org/uncovering-biomarkers-fcg-receptors/ Uncovering Biomarkers– Fcg receptors in ME/CFS] | *2016, Article - [https://batemanhornecenter.org/uncovering-biomarkers-fcg-receptors/ Uncovering Biomarkers– Fcg receptors in ME/CFS] | ||
*2016, Reductions in circulating levels of [[interleukin 16|IL-16]], [[interleukin 7|IL-7]] and [[VEGF]]-A in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref>{{Cite journal|last=Landi|first=Abdolamir|author-link=Amir Landi|last2=Broadhurst|first2=David|author-link2=|last3=Vernon|first3=Suzanne D.|author-link3=Suzanne Vernon|last4=Tyrrell|first4=D. Lorne J.|author-link4=|last5=Houghton|first5=Michael|author-link5=Michael Houghton|date=Feb 2016|title=Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S1043466615301071|journal=Cytokine|language=en|volume=78|issue=|pages=27–36|doi=10.1016/j.cyto.2015.11.018|quote=|via=}}</ref>[http://www.sciencedirect.com/science/article/pii/S1043466615301071 (Full Text)] | *2016, Reductions in circulating levels of [[interleukin 16|IL-16]], [[interleukin 7|IL-7]] and [[VEGF]]-A in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref>{{Cite journal|last=Landi|first=Abdolamir|author-link=Amir Landi|last2=Broadhurst|first2=David|author-link2=|last3=Vernon|first3=Suzanne D.|author-link3=Suzanne Vernon|last4=Tyrrell|first4=D. Lorne J.|author-link4=|last5=Houghton|first5=Michael|author-link5=Michael Houghton|date=Feb 2016|title=Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome|url=https://linkinghub.elsevier.com/retrieve/pii/S1043466615301071|journal=Cytokine|language=en|volume=78|issue=|pages=27–36|doi=10.1016/j.cyto.2015.11.018|quote=|via=}}</ref> - [http://www.sciencedirect.com/science/article/pii/S1043466615301071 (Full Text)] | ||
*2017, Epigenetic modifications and glucocorticoid sensitivity in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)]]<ref name="de Vega, 2017" /> [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324230/ (Full Text)] | *2017, Epigenetic modifications and glucocorticoid sensitivity in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)]]<ref name="de Vega, 2017" /> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324230/ (Full Text)] | ||
*2017, Neural Consequences of [[post-exertional malaise|Post-Exertion Malaise]] in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]]<ref name="Cook, 2017" /> [https://www.sciencedirect.com/science/article/pii/S088915911730051X?via%3Dihub (Full Text)] | *2017, Neural Consequences of [[post-exertional malaise|Post-Exertion Malaise]] in [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]]<ref name="Cook, 2017" /> - [https://www.sciencedirect.com/science/article/pii/S088915911730051X?via%3Dihub (Full Text)] - | ||
*2018, A [[C-reactive protein]] response in patients with post-treatment [[Lyme]] Disease symptoms versus those with [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]]<ref name="Uhde, 2018 May 8" /> [https://www.ncbi.nlm.nih.gov/pubmed/29741589 (Abstract)] | *2018, A [[C-reactive protein]] response in patients with post-treatment [[Lyme]] Disease symptoms versus those with [[ME/CFS|Myalgic Encephalomyelitis/Chronic Fatigue Syndrome]]<ref name="Uhde, 2018 May 8" /> - [https://www.ncbi.nlm.nih.gov/pubmed/29741589 (Abstract)] | ||
*2018, Integration of DNA methylation & health scores identifies subtypes in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="de Vega, 2018" /> [https://www.futuremedicine.com/doi/10.2217/epi-2017-0150 (Abstract)] | *2018, Integration of DNA methylation & health scores identifies subtypes in [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="de Vega, 2018">{{Cite journal| last1 = de Vega | first1 = Wilfred C. | authorlink1 = Wilfred de Vega| last2 = Erdman | first2 = Lauren | authorlink2 = | last3 = Vernon | first3 = Suzanne D. | authorlink3 = Suzanne Vernon| last4 = Goldenberg | first4 = Anna | authorlink4 = | last5 = McGowan | first5 = Patrick O. | authorlink5 = Patrick McGowan| title = Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome| journal = Epigenomics | volume = 10 | issue = 5 | pages = 539-557 | date = 2018| url = https://www.futuremedicine.com/doi/10.2217/epi-2017-0150 | pmid = | pmc = | doi = 10.2217/epi-2017-0150}}</ref> - [https://www.futuremedicine.com/doi/10.2217/epi-2017-0150 (Abstract)] | ||
*2018, Letter - Markers of non-coeliac wheat sensitivity in patients with [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Uhde, 2018" /> [http://gut.bmj.com/content/early/2018/03/17/gutjnl-2018-316133.long (Full Text)] | *2018, Letter - Markers of non-coeliac wheat sensitivity in patients with [[ME/CFS|myalgic encephalomyelitis/chronic fatigue syndrome]]<ref name="Uhde, 2018" /> - [http://gut.bmj.com/content/early/2018/03/17/gutjnl-2018-316133.long (Full Text)] | ||
*2018, Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref>{{Cite journal|last=Herrera|first=S|author-link=|last2=de Vega|first2=WC|author-link2=Wilfred de Vega|last3=Ashbrook|first3=D|author-link3=|last4=Vernon|first4=SD|author-link4=Suzanne Vernon|last5=McGowan|first5=PO|author-link5=Patrick McGowan|date=Dec 2018|title=Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | *2018, Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome<ref>{{Cite journal|last=Herrera|first=S|author-link=|last2=de Vega|first2=WC|author-link2=Wilfred de Vega|last3=Ashbrook|first3=D|author-link3=|last4=Vernon|first4=SD|author-link4=Suzanne Vernon|last5=McGowan|first5=PO|author-link5=Patrick McGowan|date=Dec 2018|title=Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome|journal=Epigenetics|volume=13|issue=12|pages=1174-1190| url = https://www.ncbi.nlm.nih.gov/pubmed/30516085 | pmid = 30516085 |doi=10.1080/15592294.2018.1549769|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pubmed/30516085 (Abstract)] | ||
*2019, Perturbation of effector and regulatory [[T cell]] subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)<ref>{{Cite journal|last=Karhan|first=Ece|last2=Gunter|first2=Courtney L|last3=Ravanmehr|first3=Vida|last4=Horne|first4=Meghan|last5=Kozhaya|first5=Lina|last6=Renzullo|first6=Stephanie|last7=Placek|first7=Lindsey|last8=George|first8=Joshy|last9=Robinson|first9=Peter N|last10=Vernon|first10=Suzanne D.|author-link10=Suzanne Vernon|last11=Bateman|first11=Lucinda|author-link11=Lucinda Bateman|last12=Unutmaz|first12=Derya|author-link12=Derya Unutmaz|date=2019-12-26|title=Perturbation of effector and regulatory T cell subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)|journal=biorxiv|url=http://biorxiv.org/lookup/doi/10.1101/2019.12.23.887505 | *2019, Perturbation of effector and regulatory [[T cell]] subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)<ref>{{Cite journal|last=Karhan|first=Ece|last2=Gunter|first2=Courtney L|last3=Ravanmehr|first3=Vida|last4=Horne|first4=Meghan|last5=Kozhaya|first5=Lina|last6=Renzullo|first6=Stephanie|last7=Placek|first7=Lindsey|last8=George|first8=Joshy|last9=Robinson|first9=Peter N|last10=Vernon|first10=Suzanne D.|author-link10=Suzanne Vernon|last11=Bateman|first11=Lucinda|author-link11=Lucinda Bateman|last12=Unutmaz|first12=Derya|author-link12=Derya Unutmaz|date=2019-12-26|title=Perturbation of effector and regulatory T cell subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)|journal=biorxiv|url=http://biorxiv.org/lookup/doi/10.1101/2019.12.23.887505|doi=10.1101/2019.12.23.887505}}</ref> - [https://www.biorxiv.org/content/10.1101/2019.12.23.887505v1.full (Full text)] | ||
*2020, Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients<ref>{{Cite journal|last=Lee|first=Jihyun|author-link=|last2=Vernon|first2=Suzanne D.|author-link2=Suzanne Vernon|last3=Jeys|first3=Patricia|author-link3=|last4=Ali|first4=Weam|author-link4=|last5=Campos|first5=Andrea|author-link5=|last6=Unutmaz|first6=Derya|author-link6=Derya Unutmaz|last7=Yellman|first7=Brayden|last8=Bateman|first8=Lucinda|author-link8=Lucinda Bateman|date=Dec 2020|title=Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients|url=https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02481-y|journal=Journal of Translational Medicine|language=en|volume=18|issue=1|pages=314|doi=10.1186/s12967-020-02481-y|issn=1479-5876|pmc = 7429890|pmid=32799889|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429890/ (Full text)] | *2020, Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients<ref>{{Cite journal|last=Lee|first=Jihyun|author-link=|last2=Vernon|first2=Suzanne D.|author-link2=Suzanne Vernon|last3=Jeys|first3=Patricia|author-link3=|last4=Ali|first4=Weam|author-link4=|last5=Campos|first5=Andrea|author-link5=|last6=Unutmaz|first6=Derya|author-link6=Derya Unutmaz|last7=Yellman|first7=Brayden|last8=Bateman|first8=Lucinda|author-link8=Lucinda Bateman|date=Dec 2020|title=Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients|url=https://translational-medicine.biomedcentral.com/articles/10.1186/s12967-020-02481-y|journal=Journal of Translational Medicine|language=en|volume=18|issue=1|pages=314|doi=10.1186/s12967-020-02481-y|issn=1479-5876|pmc = 7429890|pmid=32799889|access-date=|quote=|via=}}</ref> - [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429890/ (Full text)] | ||
Line 63: | Line 63: | ||
==References== | ==References== | ||
<references> | <references> | ||
<ref name="Aspler, 2008">{{ | <ref name="Aspler, 2008">{{Cite journal | last1 = Aspler | first1 = AL | authorlink1 = | ||
| last1 = Aspler | first1 = AL | authorlink1 = | |||
| last2 = Bolshin | first2 = C | authorlink2 = | | last2 = Bolshin | first2 = C | authorlink2 = | ||
| last3 = Vernon | first3 = SD | authorlink3 = Suzanne Vernon | | last3 = Vernon | first3 = SD | authorlink3 = Suzanne Vernon | ||
| last4 = Broderick | first4 = G | authorlink4 = Gordon Broderick | | last4 = Broderick | first4 = G | authorlink4 = Gordon Broderick | ||
| title = Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood | | title = Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood | ||
| journal = Behavioral and Brain Functions | volume = 4 | issue = | | journal = Behavioral and Brain Functions | volume = 4 | issue = | pages = 44| date = 2008 | url = https://behavioralandbrainfunctions.biomedcentral.com/articles/10.1186/1744-9081-4-44| pmid = | pmc =| doi = 10.1186/1744-9081-4-44}}</ref> | ||
| date = 2008 | <ref name="Broderick, 2012">{{Cite journal | ||
| doi = 10.1186/1744-9081-4-44 | |||
}} | |||
</ref> | |||
<ref name="Broderick, 2012">{{ | |||
| last1 = Broderick | first1 = Gordon | authorlink1 = Gordon Broderick | | last1 = Broderick | first1 = Gordon | authorlink1 = Gordon Broderick | ||
| last2 = Katz | first2 = Ben Z | authorlink2 = Ben Katz | | last2 = Katz | first2 = Ben Z | authorlink2 = Ben Katz | ||
Line 83: | Line 78: | ||
| last7 = O'Gorman | first7 = Maurice RG | authorlink7 = | | last7 = O'Gorman | first7 = Maurice RG | authorlink7 = | ||
| last8 = Vernon | first8 = Suzanne D | authorlink8 = Suzanne Vernon | | last8 = Vernon | first8 = Suzanne D | authorlink8 = Suzanne Vernon | ||
| last9 = Taylor | first9 = Renee | authorlink9 = Renee Taylor | | last9 = Taylor | first9 = Renee | authorlink9 = Renee Taylor | title = Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue | ||
| title = Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue | | journal = Journal of Translational Medicine | volume = 10 | issue = | pages = 191 | url = https://translational-medicine.biomedcentral.com/articles/10.1186/1479-5876-10-191 | date = 2012 | ||
| journal = Journal of Translational Medicine | volume = 10 | issue = 191 | | doi = 10.1186/1479-5876-10-191}}</ref> | ||
| date = 2012 | <ref name="Cook, 2017">{{Cite journal | ||
| doi = 10.1186/1479-5876-10-191 | |||
}} | |||
</ref> | |||
<ref name="Cook, 2017">{{ | |||
| last1 = Cook | first1 = Dane B. | authorlink1 = Dane Cook | | last1 = Cook | first1 = Dane B. | authorlink1 = Dane Cook | ||
| last2 = Light | first2 = Alan R. | authorlink2 = Alan Light | | last2 = Light | first2 = Alan R. | authorlink2 = Alan Light | ||
Line 101: | Line 92: | ||
| last9 = Stegner | first9 = Aaron J. | authorlink9 = | | last9 = Stegner | first9 = Aaron J. | authorlink9 = | ||
| last10 = Ellingson | first10 = Laura D. | authorlink10 = | | last10 = Ellingson | first10 = Laura D. | authorlink10 = | ||
| last11 = Vernon | first11 = Suzanne D. | authorlink11 = Suzanne Vernon | | last11 = Vernon | first11 = Suzanne D. | authorlink11 = Suzanne Vernon | title = Neural Consequences of Post-Exertion Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome| journal = Brain, Behavior, and Immunity | volume = 62 | issue = | pages =87-99 | url = https://www.sciencedirect.com/science/article/pii/S088915911730051X | date = 2017| pmid = | doi = 10.1016/j.bbi.2017.02.009}}</ref> | ||
| title = Neural Consequences of Post-Exertion Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | <ref name="Deftereos, 2016">{{Cite journal | last1 = Deftereos | first1 = S. N. | authorlink1 = | ||
| journal = Brain, Behavior, and Immunity | volume = | issue = | |||
| date = 2017 | |||
| pmid = | |||
| doi = 10.1016/j.bbi.2017.02.009 | |||
}} | |||
</ref> | |||
<ref name="Deftereos, 2016">{{ | |||
| last1 = Deftereos | first1 = S. N. | authorlink1 = | |||
| last2 = Vernon | first2 = S. D. | authorlink2 = Suzanne Vernon | | last2 = Vernon | first2 = S. D. | authorlink2 = Suzanne Vernon | ||
| last3 = Persidis | first3 = A. | authorlink3 = | | last3 = Persidis | first3 = A. | authorlink3 = | title = Current therapeutic strategies for myalgic encephalomyelitis/chronic fatigue syndrome: results of an online survey| journal = Fatigue: Biomedicine, Health & Behavior | volume = 4 | issue = 1 | pages = 39-51 | url = http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1126025 | ||
| title = Current therapeutic strategies for myalgic encephalomyelitis/chronic fatigue syndrome: results of an online survey | | date = 2016| pmid = | doi = 10.1080/21641846.2015.1126025}}</ref> | ||
| journal = Fatigue: Biomedicine, Health & Behavior | volume = 4 | issue = 1 | <ref name="de Vega, 2017">{{Cite journal | last1 = de Vega | first1 = Wilfred C. | authorlink1 = Wilfred de Vega | ||
| date = 2016 | |||
| pmid = | |||
| doi = 10.1080/21641846.2015.1126025 | |||
}} | |||
</ref> | |||
<ref name="de Vega, 2017">{{ | |||
| last1 = de Vega | first1 = Wilfred C. | authorlink1 = Wilfred de Vega | |||
| last2 = Herrera | first2 = Santiago | authorlink2 = | | last2 = Herrera | first2 = Santiago | authorlink2 = | ||
| last3 = Vernon | first3 = Suzanne D. | authorlink3 = Suzanne Vernon | | last3 = Vernon | first3 = Suzanne D. | authorlink3 = Suzanne Vernon | ||
| last4 = McGowan | first4 = Patrick O. | authorlink4 = Patrick McGowan | | last4 = McGowan | first4 = Patrick O. | authorlink4 = Patrick McGowan| title = Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)| journal = BMC Med Genomics | volume = 10 | issue = | pages = 11 | url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5324230/ | date = 2017 | ||
| title = Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | | pmid = | pmc = PMC5324230 | doi = 10.1186/s12920-017-0248-3}}</ref> | ||
| journal = BMC Med Genomics | volume = 10 | issue = | <ref name="Fuite, 2010">{{Cite journal | ||
| | |||
| | |||
| date = | |||
| pmid = | |||
| doi = 10. | |||
}} | |||
</ref> | |||
<ref name="Fuite, 2010">{{ | |||
| last1 = Fuite | first1 = Jim | authorlink1 = | | last1 = Fuite | first1 = Jim | authorlink1 = | ||
| last2 = Vernon | first2 = Suzanne | authorlink2 = Suzanne Vernon | | last2 = Vernon | first2 = Suzanne | authorlink2 = Suzanne Vernon | ||
| last3 = Broderick | first3 = Gordon | authorlink3 = Gordon Broderick | | last3 = Broderick | first3 = Gordon | authorlink3 = Gordon Broderick | ||
| title = Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis. | | title = Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis. | ||
| journal = Genomics | | journal = Genomics | url = https://www.sciencedirect.com/science/article/pii/S0888754308001948 | volume = 92 | issue = 6 | pages = 393-9 | ||
| date = 2008 | | date = 2008 | pmid = 18775774 | pmc = | doi = 10.1016/j.ygeno.2008.08.008}}</ref> | ||
| doi = 10.1016/j.ygeno.2008.08.008 | <ref name="Jason, Kot, 2015">{{Cite journal | last1 = Jason | first1 = LA | authorlink1 = Leonard Jason | ||
}} | |||
</ref> | |||
<ref name="Jason, Kot, 2015">{{ | |||
| last1 = Jason | first1 = LA | authorlink1 = Leonard Jason | |||
| last2 = Kot | first2 = B | authorlink2 = | | last2 = Kot | first2 = B | authorlink2 = | ||
| last3 = Sunnquist | first3 = M | authorlink3 = Madison Sunnquist | | last3 = Sunnquist | first3 = M | authorlink3 = Madison Sunnquist | ||
Line 164: | Line 117: | ||
| last7 = Newton | first7 = JL | authorlink7 = Julia Newton | | last7 = Newton | first7 = JL | authorlink7 = Julia Newton | ||
| last8 = Strand | first8 = EB | authorlink8 = Elin Strand | | last8 = Strand | first8 = EB | authorlink8 = Elin Strand | ||
| last9 = Vernon | first9 = SD | authorlink9 = Suzanne Vernon | | last9 = Vernon | first9 = SD | authorlink9 = Suzanne Vernon| title = Comparing and Contrasting Consensus versus Empirical Domains| journal = Fatigue: biomedicine, health & behavior | volume = 3 | issue = 2 | pages = 63-74| date = 2015 | url = https://pubmed.ncbi.nlm.nih.gov/26977374| pmid = 26977374 | doi = 10.1080/21641846.2015.1017344}}</ref> | ||
| title = Comparing and Contrasting Consensus versus Empirical Domains | <ref name="Jason, LA, 2014">{{Cite journal | last1 = Jason | first1 = Leonard A. | authorlink1 = Leonard Jason | ||
| journal = Fatigue: biomedicine, health & behavior | volume = 3 | issue = 2 | |||
| date = 2015 | url = https://pubmed.ncbi.nlm.nih.gov/26977374 | |||
| pmid = 26977374 | doi = 10.1080/21641846.2015.1017344}}</ref> | |||
<ref name="Jason, LA, 2014">{{ | |||
| last1 = Jason | first1 = Leonard A. | authorlink1 = Leonard Jason | |||
| last2 = Sunnquist | first2 = Madison | authorlink2 = Madison Sunnquist | | last2 = Sunnquist | first2 = Madison | authorlink2 = Madison Sunnquist | ||
| last3 = Brown | first3 = Abigail | authorlink3 = Abigail Brown | | last3 = Brown | first3 = Abigail | authorlink3 = Abigail Brown | ||
Line 178: | Line 126: | ||
| last7 = Simonis | first7 = Valerie | authorlink7 = | | last7 = Simonis | first7 = Valerie | authorlink7 = | ||
| title = Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis | | title = Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis | ||
| journal = Fatigue: Biomedicine, Health & Behavior | volume = 2 | issue = 1 | | | journal = Fatigue: Biomedicine, Health & Behavior | volume = 2 | issue = 1 | pages = 40-56| date = 2014| pmid = | pmc = PMC3912876 | url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912876/ | doi = 10.1080/21641846.2013.862993}}</ref> | ||
| date = 2014 | <ref name="Jason, Sunn, 2015">{{Cite journal | last1 = Jason | first1 = L.A. | authorlink1 = Leonard Jason | ||
| pmid = | |||
| doi = 10.1080/21641846.2013.862993 | |||
}} | |||
</ref> | |||
<ref name="Jason, Sunn, 2015">{{ | |||
| last1 = Jason | first1 = L.A. | authorlink1 = Leonard Jason | |||
| last2 = Sunnquist | first2 = M. | authorlink2 = Madison Sunnquist | | last2 = Sunnquist | first2 = M. | authorlink2 = Madison Sunnquist | ||
| last3 = Brown | first3 = A. | authorlink3 = Abigail Brown | | last3 = Brown | first3 = A. | authorlink3 = Abigail Brown | ||
| last4 = Newton | first4 = J.L. | authorlink4 = Julia Newton | | last4 = Newton | first4 = J.L. | authorlink4 = Julia Newton | ||
| last5 = Strand | first5 = E.B. | authorlink5 = Elin Strand | | last5 = Strand | first5 = E.B. | authorlink5 = Elin Strand | ||
| last6 = Vernon | first6 = S.D. | authorlink6 = Suzanne Vernon | | last6 = Vernon | first6 = S.D. | authorlink6 = Suzanne Vernon | title = Chronic fatigue syndrome versus systemic exertion intolerance disease| journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 3 | pages = 127-141| date = 2015| url = http://www.tandfonline.com/doi/full/10.1080/21641846.2015.1051291 | pmid = | doi = 10.1080/21641846.2015.1051291 }}</ref> | ||
| title = Chronic fatigue syndrome versus systemic exertion intolerance disease | <ref name="Shukla, 2015">{{Cite journal | last1 = Shukla | first1 = SK | authorlink1 = | ||
| journal = Fatigue: Biomedicine, Health & Behavior | volume = 3 | issue = 3 | | |||
| date = 2015 | |||
| pmid = | |||
| doi = 10.1080/21641846.2015.1051291 | |||
}}</ref> | |||
<ref name="Shukla, 2015">{{ | |||
| last1 = Shukla | first1 = SK | authorlink1 = | |||
| last2 = Cook | first2 = DB | authorlink2 = Dane Cook | | last2 = Cook | first2 = DB | authorlink2 = Dane Cook | ||
| last3 = Meyer | first3 = J | authorlink3 = | | last3 = Meyer | first3 = J | authorlink3 = | ||
Line 208: | Line 143: | ||
| last9 = Yale | first9 = S | authorlink9 = | | last9 = Yale | first9 = S | authorlink9 = | ||
| last10 = Frank | first10 = DN | authorlink10 = | | last10 = Frank | first10 = DN | authorlink10 = | ||
| title = Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | | title = Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)| journal = PLoS One | volume = 10 | issue = 12 | pages = e0145453| date = 2015| url = https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684203 | pmid = | pmc = PMC468420 | doi = 10.1371/journal.pone.0145453 }}</ref> | ||
| journal = PLoS One | <ref name="Uhde, 2018">{{Cite journal | ||
| date = 2015 | |||
| pmid = | |||
| doi = 10.1371/journal.pone.0145453 | |||
}} | |||
</ref> | |||
<ref name="Uhde, 2018">{{ | |||
| last1 = Uhde | first1 = M | authorlink1 = | | last1 = Uhde | first1 = M | authorlink1 = | ||
| last2 = Indart | first2 = AC | authorlink2 = | | last2 = Indart | first2 = AC | authorlink2 = | ||
Line 225: | Line 154: | ||
| last8 = Vernon | first8 = SD | authorlink8 = Suzanne Vernon | | last8 = Vernon | first8 = SD | authorlink8 = Suzanne Vernon | ||
| last9 = Alaedini | first9 = A | authorlink9 = | | last9 = Alaedini | first9 = A | authorlink9 = | ||
| title = Markers of non-coeliac wheat sensitivity in patients with myalgic encephalomyelitis/chronic fatigue syndrome | | title = Markers of non-coeliac wheat sensitivity in patients with myalgic encephalomyelitis/chronic fatigue syndrome| journal = Gut | volume = 68 | issue = | pages = 377-378 | url = https://gut.bmj.com/content/68/2/377 | date = 2018 | ||
| journal = Gut | volume = | | pmid = | doi = 10.1136/gutjnl-2018-316133}}</ref> | ||
| date = 2018 | <ref name="Uhde, 2018 May 8">{{Cite journal | last1 = Uhde | first1 = M | authorlink1 = | ||
| pmid = | |||
| doi = 10.1136/gutjnl-2018-316133 | |||
}} | |||
</ref> | |||
<ref name="Uhde, 2018 May 8">{{ | |||
| last1 = Uhde | first1 = M | authorlink1 = | |||
| last2 = Indart | first2 = AC | authorlink2 = | | last2 = Indart | first2 = AC | authorlink2 = | ||
| last3 = Fallon | first3 = BA | authorlink3 = | | last3 = Fallon | first3 = BA | authorlink3 = | ||
Line 240: | Line 163: | ||
| last6 = Vernon | first6 = SD | authorlink6 = Suzanne Vernon | | last6 = Vernon | first6 = SD | authorlink6 = Suzanne Vernon | ||
| last7 = Alaedini | first7 = A | authorlink7 = | | last7 = Alaedini | first7 = A | authorlink7 = | ||
| title = C-reactive protein response in patients with post-treatment Lyme Disease symptoms versus those with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | | title = C-reactive protein response in patients with post-treatment Lyme Disease symptoms versus those with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome| journal = Clin Infect Dis | volume = 67 | issue = 8 | pages = 1309-1310 | pmc = PMC6160605 | date = 2018| pmid = 29741589 | url = https://pubmed.ncbi.nlm.nih.gov/29741589| doi = 10.1093/cid/ciy299}}</ref> | ||
| journal = Clin Infect Dis | volume = | <ref name="Vernon, 2006">{{Cite journal | last1 = Vernon | first1 = SD | authorlink1 = Suzanne Vernon | ||
| date = 2018| pmid = 29741589 | url = https://pubmed.ncbi.nlm.nih.gov/29741589| doi = 10.1093/cid/ciy299}}</ref> | |||
<ref name="Vernon, 2006">{{ | |||
| last1 = Vernon | first1 = SD | authorlink1 = Suzanne Vernon | |||
| last2 = Whistler | first2 = T | authorlink2 = | | last2 = Whistler | first2 = T | authorlink2 = | ||
| last3 = Cameron | first3 = B | authorlink3 = | | last3 = Cameron | first3 = B | authorlink3 = | ||
| last4 = Hickie | first4 = IB | authorlink4 = Ian Hickie | | last4 = Hickie | first4 = IB | authorlink4 = Ian Hickie | ||
| last5 = Reeves | first5 = WC | authorlink5 = William Reeves | | last5 = Reeves | first5 = WC | authorlink5 = William Reeves | ||
| last6 = Lloyd | first6 = A | authorlink6 = Andrew Lloyd | | last6 = Lloyd | first6 = A | authorlink6 = Andrew Lloyd| title = Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus| journal = BMC Infectious Diseases | volume = 6 | issue = 15 | pages = | date = 2006| pmid = 16448567 | url = https://pubmed.ncbi.nlm.nih.gov/16448567| doi = 10.1186/1471-2334-6-15}}</ref> | ||
| title = Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus| journal = BMC Infectious Diseases | volume = 6 | issue = 15 | | |||
</references> | </references> | ||
[[Category:Researchers]] | [[Category:Researchers]] | ||
[[Category:US researchers]] | [[Category:US researchers]] |
Revision as of 01:26, May 17, 2022
Suzanne D. Vernon, PhD, is the Research Liaison at Bateman Horne Center of Excellence which specializes in treatment and research for ME/CFS and Fibromyalgia[1] and the Chief Scientific Revolutionary of The BioCollective, a collaborative that provides storage and sales of microbiome samples for research and development.[2]
From November 2007 to May 2015, Dr. Vernon was the Scientific Director of Solve ME/CFS Initiative, formerly known as CFIDS Association of America.[3] While there she recognized that access to well-characterized clinical populations was a barrier to engaging more scientists in ME/CFS research. Thus, she started the Research Institute Without Walls (RIWW), "the first nonprofit patient-centered research initiative focused on identifying diagnostic biomarkers and disease-modifying treatment for ME/CFS.[1] The core of RIWW is the SolveCFS BioBank & Patient Registry.[4]
From May 1990 to October 2007, Dr. Vernon worked for the US Centers for Disease Control, first on the team investigating the human papillomavirus as an opportunistic infection in HIV-infected woman, and then in 1997, she became the CFS research group team leader, under William Reeves, MD, the Director of the CDC Chronic Fatigue Research Program.[5][6]
In 2005, Dr Vernon was one of the authors of the CDC case definition of CFS, commonly called the Reeves criteria.[7]
Talks and interviews[edit | edit source]
- 2012, "Cognition & CFS: What Do We Know?" by the CFIDS Association of America with speakers Gudrun Lange and Suzanne Vernon, introduced by Kim McCleary
- 2014, Episode 70, ME/CFS Alert - Llewellyn King Interviews Dr. Suzanne Vernon
- 2015, Sleep and ME/CFS - Suzanne Vernon, PhD, A Bateman Horne Education Meeting
- 2015, [1]Spoonie Radio Episode 09 Guest - Dr. Suzanne Vernon Podcast and Full Text Transcript
- 2016, Precision Medicine for ME/CFS & Fibromyalgia
Studies and Articles[edit | edit source]
- 2003, Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution[8] - (Full Text)
- 2003, Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome[9] - (Full Text)
- 2004, Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome[10] - (Abstract)
- 2005, Chronic Fatigue Syndrome – A clinically empirical approach to its definition and study[7]
- 2006, Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study[11] - (Abstract)
- 2006, Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus[12] - (Full Text)
- 2008, Neuroendocrine and immune network remodeling in chronic fatigue syndrome: an exploratory analysis[13] - (Full Text)
- 2008, Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood.[14] - (Abstract)
- 2009, Transcriptional control of complement activation in an exercise model of chronic fatigue syndrome[15] - (Full text)
- 2012, Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue[16] -
- 2014, No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank[17] - (Full Text)
- 2014, Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis[18] -
- 2015, Chronic fatigue syndrome versus systemic exertion intolerance disease][19] - (Abstract) -
- 2015, Comparing and contrasting consensus versus empirical domains[20] - (Abstract) -
- 2015, Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)[21] - (Full Text)
- 2016, The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome[22] -(Full Text)
- 2016, Tracking post-infectious fatigue in clinic using routine Lab tests[23] - (Full Text)
- 2016, Current therapeutic strategies for myalgic encephalomyelitis/chronic fatigue syndrome: results of an online survey[24] - (Abstract)
- 2016, Article - Uncovering Biomarkers– Fcg receptors in ME/CFS
- 2016, Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome[25] - (Full Text)
- 2017, Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)[26] - (Full Text)
- 2017, Neural Consequences of Post-Exertion Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[27] - (Full Text) -
- 2018, A C-reactive protein response in patients with post-treatment Lyme Disease symptoms versus those with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[28] - (Abstract)
- 2018, Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome[29] - (Abstract)
- 2018, Letter - Markers of non-coeliac wheat sensitivity in patients with myalgic encephalomyelitis/chronic fatigue syndrome[30] - (Full Text)
- 2018, Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome[31] - (Abstract)
- 2019, Perturbation of effector and regulatory T cell subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)[32] - (Full text)
- 2020, Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients[33] - (Full text)
Online presence[edit | edit source]
Learn more[edit | edit source]
See also[edit | edit source]
References[edit | edit source]
- ↑ 1.0 1.1 "Suzanne D. Vernon, PhD". Bateman Horne Center. Retrieved February 2, 2019.
- ↑ http://www.thebiocollective.com/about-us/
- ↑ "Suzanne D. Vernon Steps Down from Scientific Director Post". Solve ME/CFS Initiative. April 8, 2015. Retrieved February 2, 2019.
- ↑ "Advancing Science: A Case for Hope, A Look Ahead". Solve ME/CFS Initiative. Retrieved June 25, 2019.
- ↑ https://www.linkedin.com/in/suzanne-d-vernon-phd-2743a617
- ↑ Grady, Denise (August 8, 2012). "Dr. William C. Reeves, Who Sought Cause of Fatigue Syndrome, Dies at 69". The New York Times. ISSN 0362-4331. Retrieved February 2, 2019.
- ↑ 7.0 7.1 Reeves, William C; Wagner, Dieter; Nisenbaum, Rosane; Jones, James F; Gurbaxani, Brian; Solomon, Laura; Papanicolaou, Dimitris A; Unger, Elizabeth R; Vernon, Suzanne D (December 2005). "Chronic Fatigue Syndrome – A clinically empirical approach to its definition and study". BMC Medicine. 3: 19. doi:10.1186/1741-7015-3-19. ISSN 1741-7015.
- ↑ Reeves, W.C.; Lloyd, A.; Vernon, S.D.; Klimas, N.; Jason, L.A.; Bleijenberg, G.; Evengard, B.; White, P.D.; Nisenbaum, R.; Unger, E. (2003). "Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution". BMC Health Services Research. 3: 25. doi:10.1186/1472-6963-3-25.
- ↑ Whistler, Toni; Unger, Elizabeth R.; Nisenbaum, Rosane; Vernon, Suzanne D. (December 1, 2003). "Integration of gene expression, clinical, and epidemiologic data to characterize Chronic Fatigue Syndrome". Journal of Translational Medicine. 1: 10. doi:10.1186/1479-5876-1-10. ISSN 1479-5876. PMC 305360. PMID 14641939.
- ↑ Rajeevan, Mangalathu S.; Jones, James F.; Vernon, Suzanne D.; Unger, Elizabeth R.; Steinau, Martin (November 1, 2004). "Differential-display PCR of peripheral blood for biomarker discovery in chronic fatigue syndrome". Journal of Molecular Medicine. 82 (11): 750–755. doi:10.1007/s00109-004-0586-4. ISSN 1432-1440.
- ↑ Hickie, Ian; Davenport, Tracey; Wakefield, Denis; Vollmer-Conna, Ute; Cameron, Barbara; Vernon, Suzanne D; Reeves, William C; Lloyd, Andrew (September 16, 2006). "Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study". BMJ. 333 (7568): 575–. doi:10.1136/bmj.38933.585764.ae. PMC 1569956. PMID 16950834.
- ↑ Vernon, SD; Whistler, T; Cameron, B; Hickie, IB; Reeves, WC; Lloyd, A (2006). "Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus". BMC Infectious Diseases. 6 (15). doi:10.1186/1471-2334-6-15. PMID 16448567.
- ↑ Fuite, Jim; Vernon, Suzanne; Broderick, Gordon (2008). "Neuroendocrine and immune network re-modeling in chronic fatigue syndrome: an exploratory analysis". Genomics. 92 (6): 393–9. doi:10.1016/j.ygeno.2008.08.008. PMID 18775774.
- ↑ Aspler, AL; Bolshin, C; Vernon, SD; Broderick, G (2008). "Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood". Behavioral and Brain Functions. 4: 44. doi:10.1186/1744-9081-4-44.
- ↑ Sorensen, Bristol; Jones, James F; Vernon, Suzanne D; Rajeevan, Mangalathu S (January 2009). "Transcriptional Control of Complement Activation in an Exercise Model of Chronic Fatigue Syndrome". Molecular Medicine. 15 (1–2): 34–42. doi:10.2119/molmed.2008.00098. PMC 2583111. PMID 19015737.
- ↑ Broderick, Gordon; Katz, Ben Z; Fernandes, Henrique; Fletcher, Mary Ann; Klimas, Nancy; Smith, Frederick A; O'Gorman, Maurice RG; Vernon, Suzanne D; Taylor, Renee (2012). "Cytokine expression profiles of immune imbalance in post-mononucleosis chronic fatigue". Journal of Translational Medicine. 10: 191. doi:10.1186/1479-5876-10-191.
- ↑ Irlbeck, David M.; Vernon, Suzanne D.; McCleary, K. Kimberly; Bateman, Lucinda; Klimas, Nancy G.; Lapp, Charles W.; Peterson, Daniel L.; Brown, James R.; Remlinger, Katja S.; Wilfret, David A.; Gerondelis, Peter (2014). "No association found between the detection of either xenotropic murine leukemia virus-related virus or polytropic murine leukemia virus and chronic fatigue syndrome in a blinded, multi-site, prospective study by the establishment and use of the SolveCFS BioBank". BMC Research Notes. 7: 461. doi:10.1186/1756-0500-7-461.
- ↑ Jason, Leonard A.; Sunnquist, Madison; Brown, Abigail; Evans, Meredyth; Vernon, Suzanne D.; Furst, Jacob D.; Simonis, Valerie (2014). "Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis". Fatigue: Biomedicine, Health & Behavior. 2 (1): 40–56. doi:10.1080/21641846.2013.862993. PMC 3912876.
- ↑ Jason, L.A.; Sunnquist, M.; Brown, A.; Newton, J.L.; Strand, E.B.; Vernon, S.D. (2015). "Chronic fatigue syndrome versus systemic exertion intolerance disease". Fatigue: Biomedicine, Health & Behavior. 3 (3): 127–141. doi:10.1080/21641846.2015.1051291.
- ↑ Jason, LA; Kot, B; Sunnquist, M; Brown, A; Reed, J; Furst, J; Newton, JL; Strand, EB; Vernon, SD (2015). "Comparing and Contrasting Consensus versus Empirical Domains". Fatigue: biomedicine, health & behavior. 3 (2): 63–74. doi:10.1080/21641846.2015.1017344. PMID 26977374.
- ↑ Shukla, SK; Cook, DB; Meyer, J; Vernon, SD; Le, T; Clevidence, D; Robertson, CE; Schrodi, SJ; Yale, S; Frank, DN (2015). "Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)". PLoS One. 10 (12): e0145453. doi:10.1371/journal.pone.0145453. PMC 468420.
- ↑ Murdock, KW; Wang, XS; Shi, Q; Cleeland, CS; Fagundes, CP; Vernon, Suzanne D. (2016). "The utility of patient-reported outcome measures among patients with myalgic encephalomyelitis/chronic fatigue syndrome". Quality of Life Research. 26: 913–921. doi:10.1007/s11136-016-1406-3. PMC 5336422. PMID 27600520.
- ↑ Harvey, Jeanna M.; Broderick, Gordon; Bowie, Alanna; Barnes, Zachary M.; Katz, Ben Z.; O'Gorman, Maurice R. G.; Vernon, Suzanne D.; Fletcher, Mary Ann; Klimas, Nancy G. (April 26, 2016). "Tracking post-infectious fatigue in clinic using routine Lab tests". BMC Pediatrics. 15: 54. doi:10.1186/s12887-016-0596-8. ISSN 1471-2431. PMC 4847210. PMID 27118537.
- ↑ Deftereos, S. N.; Vernon, S. D.; Persidis, A. (2016). "Current therapeutic strategies for myalgic encephalomyelitis/chronic fatigue syndrome: results of an online survey". Fatigue: Biomedicine, Health & Behavior. 4 (1): 39–51. doi:10.1080/21641846.2015.1126025.
- ↑ Landi, Abdolamir; Broadhurst, David; Vernon, Suzanne D.; Tyrrell, D. Lorne J.; Houghton, Michael (February 2016). "Reductions in circulating levels of IL-16, IL-7 and VEGF-A in myalgic encephalomyelitis/chronic fatigue syndrome". Cytokine. 78: 27–36. doi:10.1016/j.cyto.2015.11.018.
- ↑ de Vega, Wilfred C.; Herrera, Santiago; Vernon, Suzanne D.; McGowan, Patrick O. (2017). "Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)". BMC Med Genomics. 10: 11. doi:10.1186/s12920-017-0248-3. PMC 5324230.
- ↑ Cook, Dane B.; Light, Alan R.; Light, Kathleen C.; Broderick, Gordon; Shields, Morgan R.; Dougherty, Ryan J.; Meyer, Jacob D.; VanRiper, Stephanie; Stegner, Aaron J.; Ellingson, Laura D.; Vernon, Suzanne D. (2017). "Neural Consequences of Post-Exertion Malaise in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Brain, Behavior, and Immunity. 62: 87–99. doi:10.1016/j.bbi.2017.02.009.
- ↑ Uhde, M; Indart, AC; Fallon, BA; Wormser, GP; Marques, AR; Vernon, SD; Alaedini, A (2018). "C-reactive protein response in patients with post-treatment Lyme Disease symptoms versus those with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Clin Infect Dis. 67 (8): 1309–1310. doi:10.1093/cid/ciy299. PMC 6160605. PMID 29741589.
- ↑ de Vega, Wilfred C.; Erdman, Lauren; Vernon, Suzanne D.; Goldenberg, Anna; McGowan, Patrick O. (2018). "Integration of DNA methylation & health scores identifies subtypes in myalgic encephalomyelitis/chronic fatigue syndrome". Epigenomics. 10 (5): 539–557. doi:10.2217/epi-2017-0150.
- ↑ Uhde, M; Indart, AC; Yu, XB; Jang, SS; De Giorgio, R; Green, PHR; Volta, U; Vernon, SD; Alaedini, A (2018). "Markers of non-coeliac wheat sensitivity in patients with myalgic encephalomyelitis/chronic fatigue syndrome". Gut. 68: 377–378. doi:10.1136/gutjnl-2018-316133.
- ↑ Herrera, S; de Vega, WC; Ashbrook, D; Vernon, SD; McGowan, PO (December 2018). "Genome-epigenome interactions associated with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome". Epigenetics. 13 (12): 1174–1190. doi:10.1080/15592294.2018.1549769. PMID 30516085.
- ↑ Karhan, Ece; Gunter, Courtney L; Ravanmehr, Vida; Horne, Meghan; Kozhaya, Lina; Renzullo, Stephanie; Placek, Lindsey; George, Joshy; Robinson, Peter N; Vernon, Suzanne D.; Bateman, Lucinda; Unutmaz, Derya (December 26, 2019). "Perturbation of effector and regulatory T cell subsets in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)". biorxiv. doi:10.1101/2019.12.23.887505.
- ↑ Lee, Jihyun; Vernon, Suzanne D.; Jeys, Patricia; Ali, Weam; Campos, Andrea; Unutmaz, Derya; Yellman, Brayden; Bateman, Lucinda (December 2020). "Hemodynamics during the 10-minute NASA Lean Test: evidence of circulatory decompensation in a subset of ME/CFS patients". Journal of Translational Medicine. 18 (1): 314. doi:10.1186/s12967-020-02481-y. ISSN 1479-5876. PMC 7429890. PMID 32799889.